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Abstract  45 
Background 46 
Self-management support programmes are effective in a range of chronic conditions however there 47 
is limited evidence for their use in the treatment of chronic headaches. The aim of this study was to 48 
test the feasibility of four key aspects of a planned, future evaluative trial of a new education and self-49 
management intervention for people with chronic headache: 1) recruiting people with chronic 50 
headache from primary care; 2) a telephone interview for the classification of chronic headaches; 3) 51 
the education and self-management intervention itself; and 4) the most appropriate patient reported 52 
outcomes (PROMS).    53 
 54 
Methods 55 
Participants were identified and recruited from general practices in the West Midlands of the UK. 56 
We developed a nurse-led chronic headache classification interview and assessed agreement with 57 
an interview with headache specialists.  We developed and tested a group based education and self-58 
management intervention to assess training and delivery receipt using observation, facilitator, and 59 
participant feedback. We explored the acceptability and relevance of PROMs using postal 60 
questionnaires, interviews and a smartphone app. 61 
Results 62 
Fourteen practices took part in the study and participant recruitment equated to 1.0/1,000 63 
registered patients. Challenges to recruitment were identified. We did 107 paired headache 64 
classification interviews.  The level of agreement between nurse and doctor interviews was very 65 
good. We piloted the intervention in four groups with 18 participants. Qualitative feedback from 66 
participants and facilitators helped refine the intervention including shortening the overall 67 
intervention and increasing the facilitator training time. Participants completed 131 baseline 68 
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questionnaires, measurement data quality, reliability and validity for headache-specific and generic 69 
measures was acceptable. 70 
Conclusion 71 
This study indicated that recruiting people with chronic headache from primary care is feasible but 72 
challenging, our headache classification interview is fit for purpose, our study intervention is viable, 73 
and that our choice of outcome measures is acceptable to participants in a future randomised 74 
controlled trial (RCT).  75 
Trial Registration: ISRCTN, ISRCTN79708100. Registered 16th December 2015, 76 
http://www.isrctn.com/ISRCTN79708100 77 
 78 
Key words 79 
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 95 
Background 96 
Self-management support programmes have an established place in the management of a range of 97 
chronic diseases (1), however evidence for self-management programmes for use in chronic 98 
headaches disorders is currently limited(2). The National Institute for Health Research (NIHR) funded 99 
a programme of work (RP-PG-1212-20018) to develop, and test, a non-pharmacological approach for 100 
chronic headache using education and self-management. NIHR programme grants fund research for 101 
conditions that cause substantial disease burden and usually consist of ‘an interrelated group of high 102 
quality projects focused on a coherent theme, requiring multidisciplinary approaches, including 103 
clinical, health economics, statistics, qualitative and behavioural sciences, to ensure that research 104 
objectives can be met’. (3) Here we report the findings from a feasibility study we completed as part 105 
of our programme of work in preparation for a randomised controlled trial (RCT) evaluating the 106 
effectiveness of the intervention.  107 
We wanted to test the feasibility of four key aspects prior the planned trial.  Firstly, we wanted to test 108 
the feasibility of recruiting people with chronic headache from primary care and estimate the 109 
population base needed to recruit enough participants for the trial. Nearly a fifth of trials in 2011 were 110 
terminated for not meeting sufficient recruitment targets, and therefore unable to answer their 111 
research questions meaningfully (4).  112 
Secondly, we needed to be able to classify common chronic headaches in participants identified from 113 
primary care. Specifically we wanted to test the feasibility of using a telephone classification interview 114 
that can be used by a non-headache specialist to classify the common chronic headache disorders: 115 
chronic migraine, chronic tension type headache (TTH) and medication overuse headache (MOH). 116 
Many people with chronic headache disorders do not have an accurate diagnosis and receive 117 
inappropriate treatment of their headaches (5).  We wanted the classification interview to allow 118 
classification of headache type for both reporting and analysis purposes and to be used as part of the 119 
study intervention to allow targeted, individualised, treatment and advice.  A systematic review failed 120 
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to identify a simple classification tool fit for our purpose, we therefore needed to develop and validate 121 
a tool which can be used by a non-headache specialist to classify common chronic headache 122 
disorders(6).  123 
Thirdly, we wanted to test the feasibility of developing and delivering the education and self-124 
management support intervention for the management of common chronic headache disorders and 125 
examine the acceptability of the intervention to participants. Evaluations of complex interventions 126 
can be undermined by problems of acceptability, compliance and delivery of interventions(7).  127 
Finally, we wanted to test the quality, acceptability and appropriateness of patient reported outcome 128 
measures (PROMs) for the trial.  The selection of appropriate outcomes is crucial to the design of a 129 
trial and outcomes need to be relevant to people with chronic headaches(8). A systematic review of 130 
the quality and acceptability of patient-reported outcome measure highlighted the paucity of good 131 
quality PROM evaluations in this population and the limited focus on measurement relevance and 132 
acceptability to end-users, that is, people with headache(9). We therefore wanted to understand 133 
which outcomes are important and relevant to people with chronic headache, a population who are 134 
often young adults with work and family commitments. Additionally, electronic diaries have shown to 135 
be acceptable to participants and may have the advantage of reducing recall effects (10, 11); we 136 
wanted to test the feasibility of using a smartphone app to collect weekly data on headache frequency, 137 
duration and severity.  138 
 139 
Methods 140 
This feasibility study was designed to determine what can be done, what should be done and how it 141 
can be done well for a future  RCT(12). It was a mixed method study to test and evaluate the 142 
feasibility of a newly developed education and self-management intervention for chronic headaches, 143 
future trial recruitment methods and the most appropriate outcome measures. It included, in 144 
addition, an embedded reliability study for the classification of headaches disorders, reported in 145 
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more detail elsewhere(13). The components of the feasibility study are shown in Figure 1. We did 146 
not conduct a full pilot trial but chose to test the feasibility of four crucial components of the main 147 
randomised controlled trial due to the complexity and importance of each of these components.  148 
The study ran from January 2016 to April 2017. 149 
 150 
Patient and public involvement 151 
Patient and public involvement (PPI) was built into the key stages of the feasibility study to ensure 152 
that the research focused on issues that were important and relevant to patients and the public(14). 153 
At the start of the study we established a lay advisory group of people with chronic headache to 154 
work with collaboratively. We identified members of the group from Universities/User Teaching and 155 
Research Action Partnership (UNTRAP) at the University of Warwick and sent out an advert to our 156 
three partner headache groups: Migraine Trust, Migraine Action and National Migraine Centre (In 157 
2018 Migraine Action merged with Migraine Trust). The CHESS Lay Advisory Group specifically 158 
supported our application for ethical approval for the study, development of the headache 159 
classification interview, development of the study intervention and the choice of patient reported 160 
outcome measures. 161 
 162 
1. Feasibility of recruiting people with chronic headache from primary care  163 
The aim of this part of the study was to test the feasibility of our recruitment procedures and recruit 164 
a sample of participants to test the telephone headache classification interview, to pilot the 165 
education and self-management intervention, and to test the feasibility and the outcomes 166 
measures.  167 
Setting 168 
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We aimed to recruit patients with chronic headache registered with general (family) practices in the 169 
West Midlands region of the UK. We ran the study in three clinical commissioning groups (CCGs) in 170 
the West Midlands which cover urban, small town and semi-rural areas with varying levels of 171 
deprivation and ethnic diversity. We initially ran the study in five Clinical Research Network (CRN) 172 
West Midlands South ‘host practices’ with extensive research experience. Subsequently we 173 
purposively selected additional practices to maximise diversity and to fill groups for the pilot 174 
intervention.  We sought feedback via email using a short structured questionnaire from a small 175 
sample of General Practitioners (GPs) from the participating practices to explore their experience of 176 
taking part in the study. 177 
Participants 178 
The eligibility criteria for the feasibility study were: 179 
Inclusion Criteria:  180 
1) Aged ≥18years with chronic headache; defined as headache for 15 or more days per 181 
month for at least three months.  182 
2) Able and willing to comply with the study procedures and provide written consent.  183 
3) Fluent in written and spoken English.  184 
 185 
Exclusion Criteria:  186 
1) Has an underlying serious psychiatric or psychological disorder that precludes 187 
participation in the group intervention.  188 
2) Known secondary cause of headache other than medication overuse headache; e.g.: 189 
primary or secondary brain tumour.  190 
3) No access to a telephone.  191 
4) Currently participating in another clinical trial (with an unregistered medicinal product), 192 
or less than 90 days have passed since completing participation in such a trial.   193 
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 194 
The recruitment process to identify people for the study involved a standardised electronic search 195 
for general practice databases using Read-codes (15). Initial scoping work indicated this standard 196 
clinical terminology system for coding chronic headache was rarely used, we therefore devised a 197 
search strategy to identify patients aged ≥18 years who had consulted with headache (migraine, TTH 198 
and medication overuse headache) or had been prescribed migraine specific drugs (i.e. triptans, 199 
pizotifen) in the preceding 12 months. GPs then screened the list for patients it would be 200 
inappropriate to approach e.g. poorly controlled serious mental illness, terminal illness, or known 201 
secondary causes of headache other than medication overuse headache  202 
Potentially eligible patients were invited to participate in the study by a letter from their GP which 203 
also included a patient information leaflet informing them about the study. We also designed a 204 
study poster for display in patient waiting areas. People interested in the study were invited to 205 
contact the study team and asked the following questions to confirm eligibility:  206 
1. On average how many days in the month do you get headaches?  207 
2. How long have you been having your headaches this frequently for?  208 
3. Has this been for at least the last three months?  209 
4. Are you currently taking part in a drug trial? 210 
Patients who met the eligibility criteria were informed that they would be asked to complete two 211 
telephone headache classification calls (one by a nurse the second by a headache specialist doctor) 212 
and that they may be invited to attend the education and self-management programme and/or take 213 
part in the interview study. Potential participants also had the opportunity to have any questions 214 
answered regarding the study.  215 
Baseline packs were sent to people who were eligible and interested in the study, they included a 216 
consent form, a baseline questionnaire and a freepost return envelope. If necessary, a reminder 217 
pack was sent after two weeks. All participants were asked to provide written consent to complete 218 
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postal questionnaires, a Smartphone App and the two telephone classification interviews. Study 219 
entry was marked by receipt of the signed consent form.  220 
 221 
Sample size 222 
For the suite of work in the feasibility study we initially sought to recruit 170 people with chronic 223 
headaches from primary care. The driver for this sample size was to have sufficient data to allow us 224 
to assess the inter-rater reliability of the telephone classification interview when done by two raters; 225 
namely a nurse, and a doctor experienced in headache management. We assumed level of 226 
agreement to be 0.8, a substantial agreement(16). The initial sample size was based on measuring 227 
the level of agreement for the classification of migraine (yes/no), TTH (yes/no) and MOH (yes/no). 228 
Following our systematic review of diagnostic tools and our classification consensus meeting, the 229 
outcomes from the classification changed to measuring the level of agreement in the classification of 230 
definite chronic migraine, probable chronic migraine and chronic TTH as well as presence or absence 231 
of MOH as a nominal scale. As the analyses changed from three pairwise comparisons to two 232 
pairwise comparisons, the multiplicity adjustment also changed hence giving a revised sample size 233 
target of 153 paired interviews which was approved by the programme steering committee and the 234 
funder(17).  235 
An initial pilot search suggested that around 30/1000 people registered with a GP consult for 236 
headaches (acute, episodic or chronic) annually. Assuming that a third of these consulters had 237 
chronic headaches and a quarter of these joined the feasibility study recruitment rate would be 238 
2.5/1000 or 8.3% of those identified as consulting with headaches. Based on an average practice 239 
population of 7,000 we estimated we needed 6-10 practices with a combined list size of 64,000 240 
people to recruit our sample.  241 
 242 
2. Feasibility of a telephone classification interview to classify common headache disorders 243 
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We developed a telephone headache classification interview for use by a non-headache specialist to 244 
classify chronic headache types for reporting and analysis purposes and that could also be used as 245 
part of the study intervention to allow targeted treatment and advice.  In brief, we did a systematic 246 
literature review to identify any existing tools used to classify or diagnose different headache types 247 
which was presented to delegates at a headache classification consensus conference attended by 248 
headache specialists and people with chronic headache(6). At the consensus conference delegates 249 
agreed what were the important questions to include in the classification interview. The 250 
classification interview was not intended to have a rigid interview structure or set questions, instead 251 
the person conducting the interview was encouraged to use a logic model to inform their clinical 252 
reasoning and decision-making. 253 
We aimed to test the feasibility of training nurses to use the classification interview to classify 254 
chronic headache disorders and test the reliability of the tool. To validate the classification interview 255 
we trained six nurses, all non-headache experts, to conduct the interviews. The training included a 256 
one-day workshop delivered by a neurologist specialised in headache plus time with a member of 257 
the study team to practice classification interviews using mock scenarios and a training manual.  258 
Participants from the feasibility study were interviewed first by the nurse and later by a doctor from 259 
the National Migraine Centre. The doctor classification was the assumed ‘gold standard’. Participants 260 
were classified into: definite chronic migraine, probable chronic migraine or chronic TTH (with or 261 
without medication overuse) or ‘other’ headache type (other chronic primary headache or 262 
suspected secondary headache). We measured level of agreement between the classifications by 263 
nurses and doctors by using simple kappa statistics and prevalence-adjusted bias-adjusted kappa 264 
(PABAK).  265 
The development and evaluation of the telephone headache classification interview is described in 266 
detail elsewhere (13). 267 
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3. Feasibility and acceptability of the education and self-management support intervention 268 
for chronic headache 269 
We developed the education and self-management intervention using the Medical Research Council 270 
(MRC) framework for complex interventions(7). Development was informed by three systematic 271 
reviews 1.prognostic factors in chronic headache (18), 2. education and self-management 272 
interventions for chronic headache (19) and 3. the lived experiences of chronic headache. We drew 273 
from the experience of a previously tested self-management  intervention for chronic pain (20) and 274 
we did qualitative interviews with people with chronic headache to inform the intervention design. 275 
The qualitative interviews were with members of the charity Migraine Action to gain their views on 276 
what was important to include in the education and self-management intervention. We held a 277 
collaborative intervention design meeting, attended by headache specialist clinicians, headache 278 
charity representatives, lay people with chronic headache, psychologists, and researchers. 279 
The education and self-management intervention was intended to be delivered in a group format  280 
(8-10 per group) facilitated by a nurse and a lay person (with chronic headache). Topics included in 281 
the intervention were: understanding headache mechanisms, medication management, mood and 282 
headache, recognising unhelpful thought patterns and behaviours, stress management, sleep 283 
management, communication and mindfulness. The two and a half day programme used a range of 284 
methods including: group discussions, sharing narratives and experiences, problem solving, watching 285 
an educational DVD, role play and taster sessions. This was followed by a one to one consultation 286 
with a nurse to classify their headache type and discuss medication, lifestyle factors and goal setting, 287 
and up to eight weeks of telephone support.  288 
The development of the education and self-management interventions is described in detail 289 
elsewhere(21). 290 
We aimed to test the feasibility of the new intervention by running four groups each with up to 10 291 
participants in community settings. We approached people who lived within easy travelling distance 292 
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of proposed groups; participants provided written consent to attend the group intervention. We 293 
wanted to recruit and train two lay people and three nurses to deliver the intervention. The 294 
acceptability of the intervention was explored by conducting qualitative interviews with the 295 
participants who attended the groups and the facilitators that delivered the groups. Thematic analysis 296 
was used to identify common themes across the different components of the intervention. 297 
 298 
4. Feasibility of the patient reported outcome measures  299 
We proposed that our primary outcome measure for the RCT would be a headache-specific outcome 300 
measure collected by postal questionnaire. We initially did a systematic review of  the quality and 301 
acceptability of patient reported outcome measures for episodic and chronic headache disorders(9), 302 
and a qualitative review of the lived experience of chronic headache(22) to understand what 303 
outcomes are important to people with chronic headache. This process supported the short-listing 304 
of both headache-specific (Migraine-Specific Questionnaire v2.1(MSQv2.1) (23) and the Headache 305 
Impact Test 6-item (HIT-6)(24) and generic measures (EuroQoL EQ-5D-5L)(25) and Short-Form 12-306 
item Health Status questionnaire (SF-12)(26) to include in the feasibility study. However, the 307 
migraine-specificity of the MSQv2.1 (23) made it unsuitable for use with our chronic headache 308 
population. Therefore, with permission from the developers, the target attribute of ‘migraine’ was 309 
changed to ‘headache’ and the questionnaire renamed as the ‘Chronic Headache Quality of Life 310 
Questionnaire’ (CHQLQv1.0). We  evaluated both the acceptability and psychometric performance 311 
(data quality, reliability, validity) of the modified measure against the HIT-6, EQ-5D-5L and SF-12 (24-312 
26), providing the first evidence for the performance of the CHQLQ and HIT-6 (24) in a UK population 313 
and supporting selection for the RCT.  Structured cognitive interviews were also conducted to 314 
explore the acceptability and relevance of the measures. Informed by good practice guidance, the 315 
interviews explored how responder’s made judgements when completing the PROMs, including 316 
aspects such as question comprehension , recall and ease of completion(27, 28). The cognitive 317 
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interviews and their analysis was carried out by an experienced qualitative team with expertise in 318 
this area. 319 
Data collection:  320 
All participants were asked to complete postal questionnaires with the selected measures CHQLQ, 321 
HIT-6, SF-12 and EQ-5D-5L at baseline (the point of consent) and at two weeks and 12 weeks after 322 
the baseline questionnaire was returned. The study team posted the questionnaire with a covering 323 
letter and a freepost return envelope. After one week if the questionnaire had not been received a 324 
reminder was sent and, one week following the reminder a telephone call would be made if the 325 
questionnaire was not received.  326 
A smartphone application (app) compatible with IPhones, IPads and Android devices was designed 327 
by Clinvivo Ltd for use in the study. The app asked participants to complete three simple questions 328 
regarding the frequency, severity and duration of the headaches they experienced. The questions 329 
were developed with the involvement of the CHESS Lay Advisory Group. The app requested the data 330 
to be completed weekly for up to 12 weeks and provided notification reminders for those who 331 
accepted this option.  A small number of participants were approached to test the app; these were 332 
all participants who had recently agreed to take part in the study at the time the app was ready for 333 
testing.  334 
 335 
 336 
 337 
 338 
 339 
 340 
Results:  341 
1. Feasibility of recruiting people with chronic headache from primary care  342 
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Practice recruitment  343 
We recruited 14 general practices with a combined practice population of 128,634 (range 3,300 to 344 
16,886), see Figure 2. Feedback from the short structured email questionnaire to GPs indicated that 345 
practices were mainly interested in the study because they felt a self-management programme 346 
could potentially provide a useful alternative option for the management of patients with frequent 347 
headaches. 348 
Participant recruitment  349 
Searches of general practice data bases identified 1827 potential participants (14.2/1,000 of 350 
registered patients). GPs excluded 184 (10%) of these as inappropriate to approach. The remaining 351 
1634 (1.3% of total list size) were invited to take part in the study. We received 586 (36%) responses, 352 
of these 393 (24%) were interested in being contacted by the study team; 193 were not interested in 353 
the study. We succeeded in contacting 361/393 (92%) often after numerous attempts to get hold of 354 
people; of these potential participants 175 (48% of those contacted, 11% of those 1634 invited) 355 
were eligible. We received valid consent forms from 75% (131/175) of eligible participants (8% of 356 
those 1634 invited). Forty people failed to respond and four formally withdrew at this stage. We 357 
recruited 1.0/1,000 of practice list size.  358 
Participants mean age was 49 years (range 21-77, standard deviation, SD, 13.3). There were 108 359 
(82%) female participants, 125 (95%) of white ethnicity and 86 (66%) in full or part-time 360 
employment. About one third (n=47, 36%) left full time education between age 17 and 19, and 361 
another third (n=44, 34%) left full time education after 20 years old (Table 1). 362 
 363 
 364 
 365 
Table 1:  Participant demographics  366 
 
  Feasibility sample 
(N=131) 
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Age (years) N 128 
Mean (sd)  48.9 (13.3) 
Median (IQR)  49 (38.5,58) 
Missing 3 
Gender Male 21 (16 %) 
Female  108 (82 %) 
Missing  2 (2 %) 
Ethnicity White  125 (95 %) 
Black or Black British  2 (2 %) 
Asian or Asian British 1 (1 %) 
Mixed 1 (1 %) 
Other 1 (1% ) 
Missing 1 (1 %) 
Employment Employed (full or part-time 
including self-employment) 
 86 (66 %) 
Unemployed and looking for 
work 
 0 
At school or in full time education  2 (2 %) 
Unable to work due to long term 
sickness 
 3 (2 %) 
Looking after your home/family  11 (8 %) 
Retired from paid work  22 (17 %) 
Other  3 (2 %) 
Missing 4 (3 %) 
Age left full time 
education 
Did not receive formal education 0 
≤12 0 
13-16 35 (27 %)  
17-19  47 (36 %) 
≥20  44 (34 %) 
Still in full time education 3 (2 %) 
Other 1 (1 %) 
Missing 1 (1 %) 
 367 
2. Feasibility of the headache classification interview 368 
We trained six research nurses to conduct the telephone classification interviews. Feedback from the 369 
training indicated that the nurses felt that the training workshop, opportunity to practice interviews 370 
and the training manual prepared them adequately to carry out the classification calls and that they 371 
gained confidence the more interviews they completed. Nurses and doctors from the NMC completed 372 
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111 and 108 headache classifications interviews respectively. There were 107 paired interviews. 373 
Median days between interviews was 32 (interquartile range, IQR, 21 to 48 days). Proportion of 374 
concordance of agreement between nurses’ and doctors’ interviews was 0.91, with moderate or very 375 
good agreement on PABAK agreement in main and sensitivity analyses respectively.  Full details of 376 
these analyses are reported elsewhere(13).  377 
 378 
3. Feasibility of the education and self-management support intervention 379 
We approached 85 participants to pilot the education and self-management programme; we were 380 
unable to contact 12 (14%) participants and 46 (54%) participants were unable to attend, reasons 381 
included work commitments, dates being unsuitable, home life (including childcare) and holidays 382 
(Figure 3), 27 (32%) expressed interest in attending the intervention and of these 18 (21 %) provided 383 
written consent to attend a group.  384 
We piloted the CHESS intervention in four groups and with a total of 18 participants. The attendance 385 
at groups ranged from 3-6 participants and 17 participants attended the one-to-one consultation 386 
with the nurse. Qualitative interviews were completed with 12 participants using topic guides to 387 
explore participants’ experience of taking part in the intervention. On the whole the groups were 388 
considered acceptable and participants found the educational and self-management components 389 
useful and interesting and found the opportunity to meet with other people with chronic headache 390 
particularly helpful.  Based on participant feedback we removed the half day follow-up session 391 
because participants found the time commitment too great and we included the sessions on 392 
communication and managing setbacks at the end of day two of the programme.   393 
Facilitators gave us feedback in a focus group or interviews with the use of topic guides, including 394 
their experiences of delivering the intervention and the training received.  They reported that they 395 
did not find the two- day training adequate time to cover the delivery of the group intervention and 396 
the headache classification and medication information for the one-to-one consultations. It was also 397 
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difficult for the lay facilitators to commit to delivering the intervention due to existing work and 398 
family commitments and unpredictability of their own headaches. 399 
 400 
4. Feasibility of the patient reported outcome measures  401 
Participants completed and returned 131 baseline questionnaires; 115 (88%) and 103 (79%) 402 
questionnaires were returned at two and 12-week follow up respectively. Measurement data 403 
quality, reliability and validity for the headache-specific and generic measures was reached at 404 
acceptable standards (29, 30), supporting application of the measures with groups of patients with 405 
chronic headache. Participants in the cognitive interviews (n=14) indicated items included in the 406 
CHQLQ were comprehensive in scope and particularly welcomed those referring to the emotional 407 
impact of headache, and found the measure easy to complete.  The lack of recall period for the first 408 
three items of the HIT-6 was a concern. The generic measures were considered to be acceptable.  409 
In total eight participants downloaded the Smartphone App, participants completed the app for a 410 
duration of up to 11 weeks. A telephone call was made to a selection of participants to check they 411 
were happy using the app and although participants didn’t report difficulties downloading or using 412 
the app only one participant completed all 11 weeks of data collection and only four participants 413 
completed half or more of the weeks.  414 
 415 
Discussion:  416 
One of the key objectives for the study was to test the feasibility of recruiting people with chronic 417 
headache from primary care and estimate the population base needed to recruit enough 418 
participants for the RCT. We successfully recruited 14 general practices to the study and feedback 419 
from GPs suggested that an invitation to participate in a randomised controlled trial is likely to be 420 
well received by general practices.  421 
Recruitment to the study equated to around one per 1000 of the list size; this is comparable to 422 
recruitment rates from general practice for other studies of chronic pain (20, 31, 32). It is, however, 423 
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substantially less than our pre-study assumptions. The number of people with headaches across our 424 
pool of 14 practices was a little under half of that anticipated and the conversion rate of 7.1% from 425 
identification to consent was slightly less than pre-study assumptions. The highest identification rate 426 
was 18.3/1,000 ranging down to 8.1/1,000 (data not shown) suggesting that whilst there is great 427 
variability in coding of headache in practices our initial scoping searches were erroneous. Our 428 
conversion rate estimate was slightly optimistic and again there was a wide variability in conversion 429 
rate by practice (3.3% to 9.4%, data not shown). Consequently a wide range in recruitment rate 430 
(0.6/1,000 to 1.6/1000, data not shown). This means we under-recruited against our original target 431 
and will need to recruit participants from over 100 practices for the RCT. 432 
Overall we gained much useful information and experience from the recruitment processes for this 433 
feasibility study and we have made some important changes to our approach for the main study 434 
including allowing self-referral to the study from posters in pharmacies local to participating general 435 
practices and word of mouth media exposure.  Contacting a largely young working population was 436 
challenging often requiring numerous attempts by telephone and email and a flexible approach to 437 
contacting people outside usual working hours.  Only 75 % of those eligible to take part returned 438 
signed consent forms despite chasing. 439 
We had also not fully anticipated the challenges of making paired headache classification calls 440 
meaning we had data on fewer people than originally planned. Nevertheless we did obtain sufficient 441 
data to evaluate the agreement between nurse and doctor interviews. Non-headache specialist 442 
nurses were able to use our logic model to classify chronic headaches types and identify medication 443 
overuse headache and the level of agreement with interviews by doctors specialised in headache 444 
was good, giving us confidence in the classification interview in the RCT. 445 
We successfully piloted the intervention in four groups and gained valuable feedback from 446 
participants and facilitators. The length of the group intervention was reduced by half a day because 447 
participants, found it hard to commit more time due to work and family commitments.  Nurse 448 
facilitators requested more training in order to feel confident in headache classification and 449 
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medication advice, and an additional day training has been added in the RCT.  The group 450 
intervention was originally designed to be facilitated by a health professional and lay person with 451 
chronic headache, a model which has previously been successful for the delivery of group 452 
interventions for chronic pain (20). Because of the unpredictability of their own headaches it was not 453 
possible for the lay facilitators to commit to the role, and in the RCT the intervention will be 454 
facilitated by a nurse and an allied health professional.  Alongside the RCT we will run a process 455 
evaluation to help understand how and if the intervention works.  This will include collecting data on 456 
group attendance and interviews with a sample of participants and facilitators to explore the 457 
experience of delivering and receiving the intervention to inform any future roll out of the 458 
programme.  459 
The completion and follow up of postal questionnaires was good, and all measures were well 460 
completed by responders at all time-points. Acceptable levels of data quality, reliability and validity 461 
were found for all measures, supporting their use with groups of people and justifying selection for 462 
the RCT. Participants indicated that the modified measure the Chronic Headache Quality of Life 463 
Questionnaire was both comprehensive and comprehensible.  We were able to test our Smartphone 464 
App prior to the RCT in a small sample of participants, completion rates were poorer than 465 
anticipated and strategies to improve level of completion will be implemented in the main trial. 466 
The advice and support of PPI was integral to the intervention development and other aspects of the 467 
feasibility study and the lay advisory group will continue their contribution into the main RCT. 468 
The findings from the feasibility study have allowed us to be confident we are selecting the right 469 
participants and have a viable intervention, and allowed us to make an informed choice about 470 
outcome measures for the RCT.  The feasibility study also identified challenges in recruitment of 471 
participants with chronic headache from primary care and collecting patient reported outcome 472 
measures that we have learnt from before starting the main trail. 473 
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The CHESS RCT (ISRCTN 79708100) which commenced January 2017 will test the effectiveness and 474 
cost effectiveness of the group education and self-management intervention compared with a best 475 
usual care and a relaxation CD for people living with chronic headaches (ISRCTN 79708100).   476 
Conclusions:  477 
This study has demonstrated that recruiting people with chronic headache from primary care 478 
requires a large pool of patients which means recruiting many general practices and a flexible 479 
approach to contacting what is largely a young working population. We have developed and 480 
evaluated a telephone headache classification interview that can be used by a non-headache 481 
specialist to classify chronic headache disorders. We have provided essential evidence in support of 482 
a newly modified headache-specific measure, for application alongside established headache-483 
specific and generic measures in this population.  Despite our best efforts to involve lay people with 484 
chronic headache in the delivery of the intervention it was difficult due to their own person health; 485 
from a pragmatic stance the intervention was feasible when delivered by two health care 486 
practitioners 487 
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Figure 2 Practice and participant recruitment consort chart 660 
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 690 
Practices recruited 14 
Total practice population 128,634 
Average practice population 9188 
Identified from GP search 1827 
Excluded by GP 184 
Total number invited 1643 
Responded 586 
From initial mail out 447 
From reminder mail out 139 
Consent to approach 393 
No consent to approach 193 
Contacted 393 
Unable to contact 32 
Eligible 175 
Consented 131 
No consent 44 
Ineligible 186 
 Not fluent in English, 2  
 Not Chronic Headache 184 
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Figure 3 Reasons participants were unable to attend the group intervention 691 
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